Skip to main content

Advertisement

ADVERTISEMENT

Volume 19 - Issue 7 - July, 2007

Feature

Original Contribution
08/01/2008
Leandro I. Lasave, MD, Jose de Ribamar Costa, Jr., MD, Alexandre A. Abizaid, MD, PhD, Fausto Feres, MD, PhD, Luiz F. Tanajura, MD, PhD, Rodolfo Staico, MD, Andrea A. Abizaid, MD, PhD, Pedro Beraldo, MD, Amanda M.R. Sousa, MD, PhD, J. Eduardo M.R. Sousa, MD, PhD
Leandro I. Lasave, MD, Jose de Ribama...
Although stenting has improved clinical outcomes of patients undergoing percutaneous coronary intervention (PCI), bare-metal stents are associated with a considerable risk of restenosis.1,2 The main cause of in-stent restenosis is excessive...
Although stenting has improved clinical outcomes of patients undergoing percutaneous coronary intervention (PCI), bare-metal stents are associated with a considerable risk of restenosis.1,2 The main cause of in-stent restenosis is excessive...
Although stenting has improved...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Nicolas W. Shammas, MD, MS, Eric J. Dippel, MD, Ghassan Harb, Stephanie Egts, *Michael Jerin, PhD, Penny Stoakes, RN, Jeannette Byrd, RN, Gail A. Shammas, RN, Peter Sharis, MD
Nicolas W. Shammas, MD, MS, Eric J. D...
Interatrial septal defects (IASD) have been associated with an increased incidence of cryptogenic strokes.1–7 Percutaneous closure of these defects is now widely performed and the safety of this procedure has been established. It is unclear,...
Interatrial septal defects (IASD) have been associated with an increased incidence of cryptogenic strokes.1–7 Percutaneous closure of these defects is now widely performed and the safety of this procedure has been established. It is unclear,...
Interatrial septal defects...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
Rajesh K. Jindal, MD, Rupesh George, MD, Balbir Singh, MD
Rajesh K. Jindal, MD, Rupesh George, ...
Introduction of drug-eluting stent (DES) has led to a marked reduction in the problem of in-stent restenosis across all patient subsets and lesions complexities.7 Recently, several case reports of aneurysm formation after DES implantation...
Introduction of drug-eluting stent (DES) has led to a marked reduction in the problem of in-stent restenosis across all patient subsets and lesions complexities.7 Recently, several case reports of aneurysm formation after DES implantation...
Introduction of drug-eluting...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Vineeta Ahooja, MD and Deepak Thatai, MD
Vineeta Ahooja, MD and Deepak Thatai,...
Variant angina is a distinct clinical entity first described by Prinzmetal and associates in 1959.1 The classic presentation is characterized by chest pain occurring at rest, and is more frequent in young women. Unlike true angina, the chest...
Variant angina is a distinct clinical entity first described by Prinzmetal and associates in 1959.1 The classic presentation is characterized by chest pain occurring at rest, and is more frequent in young women. Unlike true angina, the chest...
Variant angina is a distinct...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
*§Basil M. Dudar, MD and §Henry E. Kim, MD, MPH
*§Basil M. Dudar, MD and §Henry E. ...
Rupture of atherosclerotic plaque leading to exposure of highly thrombogenic material to the blood pool with subsequent thrombus formation is the principal mechanism associated with acute coronary syndromes.1,2 Percutaneous coronary...
Rupture of atherosclerotic plaque leading to exposure of highly thrombogenic material to the blood pool with subsequent thrombus formation is the principal mechanism associated with acute coronary syndromes.1,2 Percutaneous coronary...
Rupture of atherosclerotic...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Ziad Elghoul, MD and Massoud A. Leesar, MD
Ziad Elghoul, MD and Massoud A. Leesa...
Coronary artery fistulae are uncommon vascular anomalies. The incidence of these anomalies is low, ranging from 0.2 to 0.25%.1 The fistulae frequently drain into one of the ventricles, the pulmonary arteries, the coronary sinus and the...
Coronary artery fistulae are uncommon vascular anomalies. The incidence of these anomalies is low, ranging from 0.2 to 0.25%.1 The fistulae frequently drain into one of the ventricles, the pulmonary arteries, the coronary sinus and the...
Coronary artery fistulae are...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Sorin J. Brener, MD, Steven R. Steinhubl, MD, Peter B. Berger, MD, Danielle M. Brennan, MS, Eric J. Topol, MD, for the CREDO Investigators
Sorin J. Brener, MD, Steven R. Steinh...
When clopidogrel is added to background aspirin therapy, it reduces the composite of cardiovascular death, myocardial infarction (MI) or stroke in patients with acute coronary syndromes (ACS)1 or percutaneous revascularization.2 The most...
When clopidogrel is added to background aspirin therapy, it reduces the composite of cardiovascular death, myocardial infarction (MI) or stroke in patients with acute coronary syndromes (ACS)1 or percutaneous revascularization.2 The most...
When clopidogrel is added to...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Dominique Joyal, MD, Jeffrey H. Freihage, MD, Kevin Cohoon, MD, Michael Tempelhof, MD, Ferdinand Leya, MD, Robert S. Dieter, MD, Lowell Steen, MD, Bruce Lewis, MD, Dinesh Arab, MD
Dominique Joyal, MD, Jeffrey H. Freih...
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Mehnaz Atiq, MD, Nadeem Aslam, MD, *Khawar A Kazmi, MD
Mehnaz Atiq, MD, Nadeem Aslam, MD, *K...
Patent ductus arteriosus (PDA) can cause congestive cardiac failure, repeated pneumonia, pulmonary hypertension and an increased risk for endocarditis. Transcatheter closure of PDA is currently the preferred therapeutic alternative to...
Patent ductus arteriosus (PDA) can cause congestive cardiac failure, repeated pneumonia, pulmonary hypertension and an increased risk for endocarditis. Transcatheter closure of PDA is currently the preferred therapeutic alternative to...
Patent ductus arteriosus (PDA)...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
08/01/2008
P. Syamasundar Rao, MD
P. Syamasundar Rao, MD
Patent ductus arteriosus (PDA) may be an isolated lesion or may be present in association with other defects. Isolated PDA constitutes 6–11% of all congenital heart defects. The configuration of PDA varies considerably, but most often it has...
Patent ductus arteriosus (PDA) may be an isolated lesion or may be present in association with other defects. Isolated PDA constitutes 6–11% of all congenital heart defects. The configuration of PDA varies considerably, but most often it has...
Patent ductus arteriosus (PDA)...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement